PU.1, a shared transcriptional regulator of innate and adaptive immune cell fates

Journal of Immunology

Volumn 181, Issue 3, 2008, Pages 1595-1596

  Singh, Harinder ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; TRANSCRIPTION FACTOR PU 1; ONCOPROTEIN; PROTO ONCOGENE PROTEIN SPI 1; PROTO-ONCOGENE PROTEIN SPI-1; TRANSACTIVATOR PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADAPTIVE IMMUNITY; AMINO ACID SEQUENCE; CELL FATE; GEL MOBILITY SHIFT ASSAY; GENE MUTATION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MOLECULAR CLONING; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN MOTIF; ADAPTATION; ANIMAL; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY;

ADAPTATION, BIOLOGICAL; ANIMALS; IMMUNITY, NATURAL; PROTO-ONCOGENE PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 49649112937     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.3.1595     Document Type: Note

References (32)

1. Bodner, M., J. L. Castrillo, L. E. Theill, T. Deerinck, M. Ellisman, and M. Karin. 1988. The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein. Cell 55: 505-518.
2. Ingraham, H. A., R. P. Chen, H. J. Mangalam, H. P. Elsholtz, S. E. Flynn, C. R. Lin, D. M. Simmons, L. Swanson, and M. G. Rosenfeld. 1988. A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell 55: 519-529.
3. Staudt, L. M., R. G. Clerc, H. Singh, J. H. LeBowitz, P. A. Sharp, and D. Baltimore. 1988. Cloning of a lymphoid-specific cDNA encoding a protein binding the regulatory octamer DNA motif. Science 241: 577-580.
4. Klemsz, M. J., S. R. McKercher, A. Celada, C. Van Beveren, and R. A. Maki. 1990. The macrophage and B cell-specific transcription factor PU. 1 is related to the ets oncogene. Cell 61: 113-124.
5. Moscovici, C., J. Samarut, L. Gazzolo, and M. G. Moscovici. 1981. Myeloid and erythroid neoplastic responses to avian defective leukemia viruses in chickens and in quail. Virology 113: 765-768.
6. Radke, K., H. Beug, S. Kornfeld, and T. Graf. 1982. Transformation of both erythroid and myeloid cells by E26, an avian leukemia virus that contains the myb gene. Cell 31: 643-653.
7. Moreau-Gachelin, F., A. Tavitian, and P. Tambourin. 1988. Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature 331: 277-280.
8. Rosenbauer, F., K. Wagner, J. L. Kutok, H. Iwasaki,M.M.Le Beau, Y. Okuno, K. Akashi, S. Fiering, and D. G. Tenen. 2004. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU. 1. Nat. Genet. 36: 624-630.
9. Singh, H., R. Sen, D. Baltimore, and P. A. Sharp. 1986. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature 319: 154-158.
10. Singh, H., J. H. LeBowitz, A. S. Baldwin, Jr., and P. A. Sharp. 1988. Molecular cloning of an enhancer binding protein: isolation by screening of an expression library with a recognition site DNA. Cell 52: 415-423.
11. Sen, R., and D. Baltimore. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705-716.
12. Staudt, L. M., H. Singh, R. Sen, T. Wirth, P. A. Sharp, and D. Baltimore. 1986. A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature 323: 640-643.
13. Murre, C., P. S. McCaw, and D. Baltimore. 1989. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56: 777-783.
14. Petterson, M., and W. Schaffner. 1987. A purine-richDNAsequence motif present in SV40 and lymphotropic papovavirus binds a lymphoid-specific factor and contributes to enhancer activity in lymphoid cells. Genes Dev. 1: 962-972.
15. Kodandapani, R., F. Pio, C. Z. Ni, G. Piccialli, M. Klemsz, S. McKercher, R. A. Maki, and K. R. Ely. 1996. A new pattern for helix-turn-helix recognition revealed by the PU. 1 ETS-domain-DNA complex. Nature 380: 456-460.
16. Nerlov, C., and T. Graf. 1998. PU. 1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev. 12: 2403-2412.
17. Singh, H., R. P. DeKoter, and J. C. Walsh. 1999. PU. 1, a shared transcriptional regulator of lymphoid and myeloid cell fates. Cold Spring Harb. Symp. Quant. Biol. 64: 13-20.
18. Zhang, P., X. Zhang, A. Iwama, C. Yu, K. A. Smith, B. U. Mueller, S. Narravula, B. E. Torbett, S. H. Orkin, and D. G. Tenen. 2000. PU. 1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding. Blood 96: 2641-2648.
19. Eisenbeis, C. F., H. Singh, and U. Storb. 1993. PU. 1 is a component of a multiprotein complex which binds an essential site in the murine immunoglobulin lambda 2-4 enhancer. Mol. Cell Biol. 13: 6452-6461.
20. Pongubala, J. M., S. Nagulapalli, M. J. Klemsz, S. R. McKercher, R. A. Maki, and M. L. Atchison. 1992. PU. 1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3′ enhancer activity. Mol. Cell. Biol. 12: 368-378.
21. Scott, E. W., M. C. Simon, J. Anastasi, and H. Singh. 1994. Requirement of transcription factor PU. 1 in the development of multiple hematopoietic lineages. Science 265: 1573-1577.
22. McKercher, S. R., B. E. Torbett, K. L. Anderson, G. W. Henkel, D. J. Vestal, H. Baribault, M. Klemsz, A. J. Feeney, G. E. Wu, C. J. Paige, and R. A. Maki. 1996. Targeted disruption of the PU. 1 gene results in multiple hematopoietic abnormalities. EMBO J. 15: 5647-5658.
23. Scott, E. W., R. C. Fisher, M. C. Olson, E. W. Kehrli, M. C. Simon, and H. Singh. 1997. PU. 1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors. Immunity 6: 437-447.
24. Glimcher, L. H., and H. Singh. 1999. Transcription factors in lymphocyte development - T and B cells get together. Cell 96: 13-23.
25. DeKoter, R. P., and H. Singh. 2000. Regulation of B lymphocyte and macrophage development by graded expression of PU. 1. Science 288: 1439-1441.
26. DeKoter, R. P., J. C. Walsh, and H. Singh. 1998. PU. 1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors. EMBO J. 17: 4456-4468.
27. Hohaus, S., M. S. Petrovick, M. T. Voso, Z. Sun, D. E. Zhang, and D. G. Tenen. 1995. PU. 1 (Spi-1) and C/EBPα regulate expression of the granulocyte-macrophage colony-stimulating factor receptor α gene. Mol. Cell. Biol. 15: 5830-5845.
28. Zhang, D. E., C. J. Hetherington, H. M. Chen, and D. G. Tenen. 1994. The macrophage transcription factor PU. 1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol. Cell. Biol. 14: 373-381.
29. DeKoter, R. P., H. J. Lee, and H. Singh. 2002. PU. 1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity 16: 297-309.
30. Walsh, J. C., R. P. DeKoter, H. J. Lee, E. D. Smith, D. W. Lancki, M. F. Gurish, D. S. Friend, R. L. Stevens, J. Anastasi, and H. Singh. 2002. Cooperative and antagonistic interplay between PU. 1 and GATA-2 in the specification of myeloid cell fates. Immunity 17: 665-676.
31. Laslo, P., C. J. Spooner, A. Warmflash, D. W. Lancki, H. J. Lee, R. Sciammas, B. N. Gantner, A. R. Dinner, and H. Singh. 2006. Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell 126: 755-766.
32. Medina, K. L., J. M. Pongubala, K. L. Reddy, D. W. Lancki, R. Dekoter, M. Kieslinger, R. Grosschedl, and H. Singh. 2004. Assembling a gene regulatory network for specification of the B cell fate. Dev. Cell 7: 607-617.